Internal Medicine Alert - June 30, 2010

Target Audience:

This activity is intended for the internist and family practitioner.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/01/10. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of each issue.


Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Allan J. Wilke, MD, MA
Professor and Chair
Department of Integrative Medicine
Ross University (Bahamas)
Limited, Freeport, Grand Bahama, The Bahamas

Joseph E. Scherger, MD, MPH
Clinical Professor
University of California, San Diego

Barbara A. Phillips, MD, MSPH
Professor of Medicine,
University of Kentucky;
Director, Sleep Disorders Center,
Samaritan Hospital,

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY


  • Alcohol Consumption and Mortality in Patients with CVD
  • Another Argument for Moderation in All Things
  • Silent Pulmonary Emboli in Patients with DVT: Time to Screen?
  • How Much Physical Activity to Avoid Weight Gain?
  • Miconazole Buccal Tablets (Oravig™)
  • Clinical Briefs By Louis Kuritzky, MD


  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, serves on the advisory boards of Amylin, Kowa, and Novo Nordisk; and serves on the speakers bureaus of Boehringer Ingelheim and Novo Nordisk. Associate editors Joseph E. Scherger, MD, MPH, Allan J. Wilke, MD, MA, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study. Associate editor Barbara A. Phillips, MD, MSPH is a consultant for Cephalon, and serves on the speakers bureaus for Resmed and Respironics. Associate editor Louis Kuritzky, MD is a consultant for Sucampo Pharmaceuticals, Takeda, Boehringer Ingelheim; and is a consultant and on the speaker's bureau for Novo Nordisk, Lilly, Daiichi Sankyo, Forest Pharmaceuticals, Cephalon, Novartis, and Sanofi Aventis.

Copyright 2010 AHC Media. All rights reserved.